藥品參考
Oritavancin
Oritavancin is a medicine in the class anti bacterial. It is used for skin infections.
- 藥物類別: Anti Bacterial
- 用途: skin infections
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Anti Bacterial
- ATC 代碼
- J01XA05
- 常見劑型
- 注射劑
- 常見規格
- 400 mg, 1200 mg/40 ml
- 已知交互作用
- 12 (禁忌併用: 1 · 中度: 1 · 輕微: 10)
- 商品名
- 3
- 國家與市場
- 2
用途
作用方式
Oritavancin is a lipoglycopeptide antibacterial drug; the label gives no further mechanism detail.
成人常用劑量（仿單摘要）
ABSSSI (adults 18 years and older): 1,200 mg as a single dose by intravenous infusion over 1 hour.
懷孕與哺乳
- 懷孕
- Unknown No human data; no effects on embryo-fetal development or survival in rats or rabbits at doses about 25% of the single clinical dose. Weigh the need for this single-dose antibiotic against the unknown risk.
- 哺乳
- Unknown No human milk data; it passes into rat milk. LactMed: poorly absorbed by mouth, so unlikely to reach the infant's blood; watch for diarrhoea or thrush. With no published experience, an alternative may be preferred, especially with a newborn or preterm infant.
已通報的副作用
- Headache
- Nausea
- Vomiting
- Limb and subcutaneous abscesses
- Diarrhea
禁忌症
- Intravenous unfractionated heparin is contraindicated for 120 hours (5 days) after administration because aPTT may remain falsely elevated.
- Known hypersensitivity to oritavancin products.
哪些人需要特別留意
- Coagulation test interference: aPTT prolonged up to 120 hours, PT/INR up to 12 hours, ACT up to 24 hours; consider a chromogenic Factor Xa assay or an alternative anticoagulant not requiring aPTT.
- Serious hypersensitivity including anaphylaxis; discontinue infusion if it occurs and monitor patients with glycopeptide allergy.
- Infusion related reactions; stopping or slowing the infusion may stop them.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (12)
- Heparin + Oritavancin Contraindicated
- Oritavancin + Warfarin Moderate
- Carbamazepine + Oritavancin Minor
- Cyclosporin + Oritavancin Minor
- Ethosuximide + Oritavancin Minor
- Flecainide + Oritavancin Minor
- Oritavancin + Phenytoin Minor
- Oritavancin + Quinidine Minor
- Oritavancin + Quinine Minor
- Oritavancin + Sirolimus Minor
Pro+ 會員專屬
解鎖完整頁面
建立帳號並開始 Pro+ 試用，即可開啟 Oritavancin 的完整藥品專論：劑量、懷孕與哺乳、副作用、警示及所有交互作用。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
在網頁版免費試用 Pro+ 14 天，無需信用卡。
常見問題
What is Oritavancin used for?
Oritavancin is a medicine in the class anti bacterial. It is used for Skin infections.
What side effects have been reported with Oritavancin?
Headache, Nausea, Vomiting, Limb and subcutaneous abscesses, Diarrhea.
Can Oritavancin be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human data; no effects on embryo-fetal development or survival in rats or rabbits at doses about 25% of the single clinical dose. Weigh the need for this single-dose antibiotic against the unknown risk. Breastfeeding: Unknown. No human milk data; it passes into rat milk. LactMed: poorly absorbed by mouth, so unlikely to reach the infant's blood; watch for diarrhoea or thrush. With no published experience, an alternative may be preferred, especially with a newborn or preterm infant.
What does Oritavancin interact with?
MediHelp lists 12 known interactions for Oritavancin. Contraindicated: 1 · Moderate: 1 · Minor: 10. The most serious include Heparin, Warfarin, Carbamazepine.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
